| scholarly article | Q13442814 |
| P50 | author | Francisco Sánchez-Madrid | Q40058345 |
| Francisco Lozano | Q41581141 | ||
| María Mittelbrunn | Q50236822 | ||
| Carlos Enrich | Q51749227 | ||
| P2093 | author name string | Idoia Gimferrer | |
| Maria Calvo | |||
| Maria Rosa Sarrias | |||
| Jordi Vives | |||
| Montse Farnós | |||
| P2860 | cites work | Properties of the extracellular calcium binding module of the proteoglycan testican | Q24315998 |
| Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand | Q24319426 | ||
| Tyrosine phosphorylation of CD6 by stimulation of CD3: augmentation by the CD4 and CD2 coreceptors | Q24680696 | ||
| Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction | Q28212934 | ||
| Three-dimensional segregation of supramolecular activation clusters in T cells | Q28282528 | ||
| A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts | Q28282813 | ||
| The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site | Q28288267 | ||
| OX52 is the rat homologue of CD6: evidence for an effector function in the regulation of CD5 phosphorylation | Q28568057 | ||
| Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5 | Q28574573 | ||
| Human CD6 possesses a large, alternatively spliced cytoplasmic domain | Q30193083 | ||
| Quantitative fluorescence resonance energy transfer measurements using fluorescence microscopy | Q32063501 | ||
| The immunological synapse and the actin cytoskeleton: molecular hardware for T cell signaling. | Q33958592 | ||
| The accessory molecules CD5 and CD6 associate on the membrane of lymphoid T cells | Q34163553 | ||
| The immunological synapse. | Q34178149 | ||
| Analysis of the tyrosine phosphorylation and calcium fluxing of human CD6 isoforms with different cytoplasmatic domains. | Q34448840 | ||
| CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics | Q34738334 | ||
| The Scavenger Receptor Cysteine-Rich (SRCR) domain: an ancient and highly conserved protein module of the innate immune system | Q35680326 | ||
| Proliferating dendritic cell progenitors in human blood | Q36363279 | ||
| Identification and characterization of a 100-kD ligand for CD6 on human thymic epithelial cells | Q36364656 | ||
| Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, beta 1-integrins, and beta 2-integrins | Q36534910 | ||
| CD5 Inhibits Signaling at the Immunological Synapse Without Impairing Its Formation | Q40653202 | ||
| ALCAM (CD166): its role in hematopoietic and endothelial development. | Q40778909 | ||
| Noncovalent associations of T lymphocyte surface proteins | Q41161806 | ||
| The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD6 with a 1:1 stoichiometry | Q41183840 | ||
| CD6-ligand interactions: a paradigm for SRCR domain function? | Q41633008 | ||
| Frontline: Optimal T cell activation requires the engagement of CD6 and CD166. | Q47867827 | ||
| Simultaneous cross-linking of CD6 and CD28 induces cell proliferation in resting T cells | Q47927433 | ||
| Biochemical characterization of recombinant and circulating human Spalpha. | Q47978702 | ||
| The duration of antigenic stimulation determines the fate of naive and effector T cells. | Q51099389 | ||
| CD6: expression during development, apoptosis and selection of human and mouse thymocytes. | Q53969369 | ||
| Triggering the TCR Complex Causes the Downregulation of Nonengaged Receptors by a Signal Transduction-Dependent Mechanism | Q56922108 | ||
| Role of ICAM-3 in the initial interaction of T lymphocytes and APCs | Q57941405 | ||
| Conjugation of antibodies with fluorochromes: modifications to the standard methods | Q67499849 | ||
| Recombinant expression and properties of the human calcium-binding extracellular matrix protein BM-40 | Q68253163 | ||
| Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59 | Q71640765 | ||
| Mutational analysis of the CD6 binding site in activated leukocyte cell adhesion molecule | Q71832548 | ||
| Physical association of CD5 and the T cell receptor/CD3 antigen complex on the surface of human T lymphocytes | Q72077887 | ||
| Identification of a natural soluble form of human CD5 | Q72995648 | ||
| Interaction of EGF receptor and grb2 in living cells visualized by fluorescence resonance energy transfer (FRET) microscopy | Q73205125 | ||
| Mutational analysis of the CD6 ligand binding domain | Q73986800 | ||
| High circulating levels of soluble scavenger receptors (sCD5 and sCD6) in patients with primary Sjögren's syndrome | Q74523535 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | T cell activation | Q14863969 |
| CD6 molecule | Q21113034 | ||
| activated leukocyte cell adhesion molecule | Q21113038 | ||
| P304 | page(s) | 2262-70 | |
| P577 | publication date | 2004-08-15 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Relevance of CD6-mediated interactions in T cell activation and proliferation | |
| P478 | volume | 173 |
| Q37390483 | A clinical exploratory study with itolizumab, an anti-CD6 monoclonal antibody, in patients with rheumatoid arthritis |
| Q64882785 | A sequence conserved between CD5 and CD6 binds an FERM domain and exerts a restraint on T-cell activation. |
| Q39704758 | ALCAM is associated with chemoresistance and tumor cell adhesion in pancreatic cancer |
| Q39262727 | ALCAM/CD166 adhesive function is regulated by the tetraspanin CD9. |
| Q35609716 | ALCAM: Basis Sequence: Mouse |
| Q60446155 | Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system |
| Q37086373 | Activated leukocyte cell adhesion molecule: a new paradox in cancer |
| Q58874863 | Antibodies in Phase III Studies for Immunological Disorders |
| Q57816679 | Biophysical Characterization of CD6-TCR/CD3 Interplay in T Cells |
| Q35786301 | Breaking and entering into the CNS: clues from solid tumor and nonmalignant models with relevance to hematopoietic malignancies |
| Q99582701 | CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer |
| Q48023143 | CD6 Receptor Regulates Intestinal Ischemia/Reperfusion-induced Injury by Modulating Natural IgM-producing B1a Cell Self-renewal |
| Q51298176 | CD6 and Linker of Activated T Cells are Potential Interaction Partners for T Cell-Specific Adaptor Protein. |
| Q34337963 | CD6 as a therapeutic target in autoimmune diseases: successes and challenges. |
| Q35818957 | CD6 attenuates early and late signaling events, setting thresholds for T-cell activation |
| Q24315988 | CD6 binds to pathogen-associated molecular patterns and protects from LPS-induced septic shock |
| Q37179020 | CD6 modulates thymocyte selection and peripheral T cell homeostasis |
| Q88716412 | CD6 monoclonal antibodies differ in epitope, kinetics and mechanism of action |
| Q24670421 | CD6 regulates T-cell responses through activation-dependent recruitment of the positive regulator SLP-76 |
| Q38341487 | CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction |
| Q60949699 | CD6, a Rheostat-Type Signalosome That Tunes T Cell Activation |
| Q26771983 | Cell Adhesion Molecules and Ubiquitination-Functions and Significance |
| Q42021757 | Cloning of the human activated leukocyte cell adhesion molecule promoter and identification of its tissue-independent transcriptional activation by Sp1. |
| Q37474894 | Dynamic regulation of T-cell costimulation through TCR-CD28 microclusters |
| Q90470963 | Endophilin-A3 and Galectin-8 control the clathrin-independent endocytosis of CD166 |
| Q33605328 | Evolution of the CD163 family and its relationship to the bovine gamma delta T cell co-receptor WC1. |
| Q36175628 | Expression and Role of CD166 in the Chronic Kidney Disease |
| Q34701324 | Fine mapping and functional analysis of the multiple sclerosis risk gene CD6 |
| Q49962988 | Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis. |
| Q33857839 | Human CD6 Down-Modulation following T-Cell Activation Compromises Lymphocyte Survival and Proliferative Responses |
| Q56896657 | Human treg cells are characterized by low/negative CD6 expression |
| Q33573621 | Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumab |
| Q37138277 | Immunological evaluation of rheumatoid arthritis patients treated with itolizumab |
| Q38461733 | Itolizumab - a humanized anti-CD6 monoclonal antibody with a better side effects profile for the treatment of psoriasis |
| Q39033726 | Itolizumab, a novel anti-CD6 monoclonal antibody: a safe and efficacious biologic agent for management of psoriasis |
| Q35005863 | JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals |
| Q24298706 | Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells |
| Q93084543 | Modulation of CD4 T cell function via CD6-targeting |
| Q24299519 | Modulation of CD6 function through interaction with Galectin-1 and -3 |
| Q35787684 | Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis |
| Q90690087 | Multifaceted effects of soluble human CD6 in experimental cancer models |
| Q36925666 | Pathogenesis of endometriosis: the role of defective 'immunosurveillance'. |
| Q39147545 | Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis. |
| Q33269787 | Quantitative membrane proteomics reveals new cellular targets of viral immune modulators |
| Q28771480 | Quantitative proteomics analysis of signalosome dynamics in primary T cells identifies the surface receptor CD6 as a Lat adaptor-independent TCR signaling hub |
| Q38730494 | Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases |
| Q38726869 | Relevance of CD6-Mediated Interactions in the Regulation of Peripheral T-Cell Responses and Tolerance |
| Q37800163 | Review: leucocyte-endothelial cell crosstalk at the blood-brain barrier: a prerequisite for successful immune cell entry to the brain |
| Q35943010 | Structures of CD6 and Its Ligand CD166 Give Insight into Their Interaction |
| Q33715887 | T Cell Costimulation by CD6 Is Dependent on Bivalent Binding of a GADS/SLP-76 Complex |
| Q33865748 | T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab |
| Q42239720 | Targeting of key pathogenic factors from gram-positive bacteria by the soluble ectodomain of the scavenger-like lymphocyte receptor CD6. |
| Q55047515 | Tetraspanin CD9: A Key Regulator of Cell Adhesion in the Immune System. |
| Q37083637 | The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome |
| Q50672826 | The Cd6 gene as a permissive locus for targeted transgenesis in the mouse. |
| Q26853175 | The conserved scavenger receptor cysteine-rich superfamily in therapy and diagnosis |
| Q27002959 | The immunological synapse: the gateway to the HIV reservoir |
| Q37105137 | Transcriptional and functional characterization of CD137L-dendritic cells identifies a novel dendritic cell phenotype. |
| Q37483915 | Transgenic expression of soluble human CD5 enhances experimentally-induced autoimmune and anti-tumoral immune responses |
Search more.